Showing posts with label NDA for for the Treatment of Postmenopausal Women with Osteoporosis. Show all posts
Showing posts with label NDA for for the Treatment of Postmenopausal Women with Osteoporosis. Show all posts
Wednesday, January 4, 2017

Radius Announces FDA Acceptance for Filing of NDA for for the Treatment of Postmenopausal Women with Osteoporosis

›
Radius Health, Inc. ), a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of ...